| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Integrum AB Q2 Loss Narrows | 1 | RTTNews | ||
| Fr | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 69 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11. | Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation | 1 | Cision News | ||
| 19.11. | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 211 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 18.11. | INTEGRUM AB: The subscription period in Integrum's rights issue has begun | 1 | Cision News | ||
| 13.11. | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 126 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11. | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 211 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11. | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 104 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 23.10. | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 133 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10. | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 136 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10. | Integrum: $2.5 Billion Fund II Closed, Bringing Total Assets To $5 Billion | 2 | pulse2.com | ||
| 16.10. | Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report | 177 | GlobeNewswire (Europe) | The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential... ► Artikel lesen | |
| 16.10. | Integrum AB: Integrum provides operational update ahead of Q2 report | 89 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen | |
| 01.10. | Duke Capital - Follow-On Investment into Integrum Group Holdings | 4 | RNS | ||
| 25.09. | The observation status for Integrum AB is removed | 174 | GlobeNewswire | On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a... ► Artikel lesen | |
| 18.09. | INTEGRUM AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information | 4 | Cision News | ||
| 17.09. | INTEGRUM AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer | 1 | Cision News | ||
| 16.09. | OSTEOCENTRIC ONCOLOGY AND BONE ANCHORED PROSTHESES LLC: FINAL OUTCOME FOR THEIC OFFER BY OSTEOCENTRIC TO THE SHAREHOLDERS OF INTEGRUM: OSTEOCENTRIC DOES NOT COMPLETE THE OFFER | 3 | Cision News | ||
| 04.09. | INTEGRUM AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly | 1 | Cision News | ||
| 01.09. | Integrum AB: Stronger positioning paves the way for continued growth | 111 | GlobeNewswire (Europe) | First quarter 2025/26 (May - July)
Net sales amounted to SEK 23.8 (18.5) million.
Operating loss totalled SEK 12.4 (12.0) million.
Profit/loss after tax amounted to SEK -10.0 (-9.4) million.
Earnings... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 90,81 | -0,32 % | Medtronic Spark Scholarship Launches To Help Students From Low-Income Households Globally Pursue Health Tech Careers | Medtronic Spark Scholarship provides financial assistance and access to support services for students pursuing health tech and related degrees NORTHAMPTON, MA / ACCESS Newswire / November 20, 2025 /... ► Artikel lesen | |
| INTUITIVE SURGICAL | 502,40 | +0,36 % | ISRG vs. MDT: A High-Tech Robotics Faceoff in the Race for Leadership | ||
| THERMO FISHER | 515,30 | -0,31 % | Thermo Fisher Scientific Subsidiary Prices EUR 2.1 Bln Senior Notes Offering | HONG KONG (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) has priced an offering of 2.1 billion euros aggregate principal amount of euro-denominated notes, to be issued by Thermo Fisher Scientific... ► Artikel lesen | |
| STRATEC | 21,800 | +2,35 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Stratec von 30 auf 27 Euro gesenkt, aber die Einstufung auf "Hold" belassen. Die jüngst vom Unternehmen gekappten Ziele für... ► Artikel lesen | |
| HIMS & HERS HEALTH | 32,420 | +1,06 % | Why Is Hims & Hers Stock Falling, and Should Investors Buy the Dip? | ||
| EUROFINS SCIENTIFIC | 58,64 | -1,31 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| BECTON DICKINSON | 169,40 | +0,27 % | BD Launches Surgiphor Surgical Wound Irrigation System In Europe | WASHINGTON (dpa-AFX) - Becton, Dickinson and Company (BDX), a medical technology company, said Monday that it has launched the BD Surgiphor Surgical Wound Irrigation System in Europe. The system... ► Artikel lesen | |
| FAMICORD | 5,250 | 0,00 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| GERATHERM MEDICAL | 3,390 | 0,00 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 87,80 | 0,00 % | Boston Scientific's Margins Strengthen in Q3: What's Driving It? | ||
| PAUL HARTMANN | 220,00 | -0,90 % | Januar bis September 2025: PAUL HARTMANN steigert Umsatz trotz schwächerer Absatzmärkte | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.826,0 Mio. EUR, organisches Umsatzwachstum von 2,0 % - Bereinigtes EBITDA liegt bei 195,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,7 % - Unternehmen... ► Artikel lesen | |
| RESMED | 222,30 | +0,50 % | RESMED INC: 144 Report of proposed sale of securities | ||
| MCKESSON | 767,80 | -0,18 % | Iterum Therapeutics: Vertriebsstart für Antibiotikum ORLYNVAH über McKesson | ||
| INMODE | 12,315 | +0,86 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |